22346109|t|Diabetic macular edema: current and emerging therapies.
22346109|a|Diabetic macular edema is a leading cause of vision impairment among people within the working- age population. This review discusses the pathogenesis of diabetic macular edema and the treatment options currently available for the treatment of diabetic macular edema, including for focal/grid photocoagulation, intravitreal corticosteroids and intravitreal anti-vascular endothelial growth factor agents. The biologic rationale for novel therapeutic agents, many of which are currently being evaluated in clinical trials, also is reviewed.
22346109	0	22	Diabetic macular edema	Disease	MESH:D008269
22346109	56	78	Diabetic macular edema	Disease	MESH:D008269
22346109	101	118	vision impairment	Disease	MESH:D014786
22346109	210	232	diabetic macular edema	Disease	MESH:D008269
22346109	300	322	diabetic macular edema	Disease	MESH:D008269
22346109	418	452	vascular endothelial growth factor	Gene	7422
22346109	Association	MESH:D008269	7422

